XpresCheck™ to Open COVID-19 Testing Facility at Hartsfield-Jackson Atlanta International Airport
XpresSpa Group, Inc. (Nasdaq: XSPA) (“XpresSpa” or the “Company”),
a health and wellness company, today announced that it plans to
open a new XpresCheck COVID-19 testing facility in
Hartsfield-Jackson Atlanta International Airport (ATL). The
location is slated to open in mid-October.
The Company will be converting a legacy XpresSpa
located in Concourse E to XpresCheck. This testing facility will
include 6 separate testing rooms with the capacity to administer
over 400 tests per day. COVID-19 testing options will include a
Rapid Molecular COVID-19 Test and a Rapid Polymerase Chain Reaction
“With a sustained increase in testing demand, we
are thrilled to bring
an XpresCheck to Hartsfield-Jackson Atlanta
International Airport, the world’s second busiest airport and home
to the CDC,” said Doug Satzman, XpresSpa CEO. “Atlanta has
historically been one of our most successful markets, with four
XpresSpas in operation throughout the airport pre-pandemic, and we
are currently operating an XpresSpa in Concourse A. Through
XpresCheck, we will now be able to offer travelers and airline
employees convenient COVID-19 testing options at this on-site
testing facility. With consumers resuming travel, we are pleased to
be providing this additional layer of safety.”
About XpresSpa Group, Inc.
XpresSpa Group, Inc. (Nasdaq: XSPA) is a leading
global health and wellness holding company operating three distinct
brands: Treat™, XpresCheck™, and XpresSpa™. Treat is a travel
health and wellness brand that will be providing on-demand access
to healthcare through technology and personalized services.
XpresCheck is a leading on-site airport provider of COVID-19
screening and testing with 13 locations in 11 domestic airports.
XpresSpa is a leading airport retailer of spa services and related
health and wellness products, with 43 locations in 21 airports
To learn more about XpresSpa Group, visit:
www.XpresSpaGroup.com.To learn more about Treat, visit:
www.TreatCare.com.To learn more about XpresCheck, visit:
www.XpresCheck.com.To learn more about XpresSpa, visit
Twitter: @Treat_Care and Instagram:
@treat_careTwitter: @xprescheck and Instagram:
@realxprescheckTwitter: @XpresSpa and Instagram: @XpresSpa
This press release may contain "forward-looking"
statements within the meaning of Section 27A of the Securities Act
of 1933, and Section 21E of the Securities Exchange Act of 1934.
These include statements preceded by, followed by or that otherwise
include the words "believes," "expects," "anticipates,"
"estimates," "projects," "intends," "should," "seeks," "future,"
"continue," or the negative of such terms, or other comparable
terminology. Forward-looking statements relating to expectations
about future results or events are based upon information available
to XpresSpa Group as of today's date and are not guarantees of the
future performance of the Company, and actual results may vary
materially from the results and expectations discussed. Additional
information concerning these and other risks is contained in
XpresSpa Group’s most recently filed Annual Report on Form 10-K,
Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, and
other Securities and Exchange Commission filings. All subsequent
written and oral forward-looking statements concerning XpresSpa
Group, or other matters and attributable to XpresSpa Group or any
person acting on its behalf are expressly qualified in their
entirety by the cautionary statements above. XpresSpa Group does
not undertake any obligation to publicly update any of these
forward-looking statements to reflect events or circumstances that
may arise after the date hereof.
Historical Stock Chart
From Dec 2021 to Jan 2022
Historical Stock Chart
From Jan 2021 to Jan 2022